Robert J. Chorvat
72Patents
14h-index
35Co-inventors
84Inventor score
Filing activity: May 6, 1974 → Jul 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6107301A | 1N-alkyl-N-arylpyrimidinamines and derivatives thereof | Chemistry; Metallurgy | 89 | Expired |
| US6342503B1 | 1N-alkyl-n-arylpyrimidinamines and derivatives thereof | Chemistry; Metallurgy | 89 | Expired |
| US6060478A | Azolo triazines and pyrimidines | Chemistry; Metallurgy | 68 | Expired |
| US6191131A | Azolo triazines and pyrimidines | Chemistry; Metallurgy | 59 | Expired |
| US7655685B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Chemistry; Metallurgy | 50 | Active |
| US6448261B1 | Arylamino fused pyridines | Chemistry; Metallurgy | 35 | Expired |
| US6124289A | Azolo triazines and pyrimidines | Chemistry; Metallurgy | 31 | Expired |
| US8133904B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating obesity | Chemistry; Metallurgy | 26 | Active |
| US6313124A | Tetrazine bicyclic compounds | Chemistry; Metallurgy | 24 | Expired |
| US6107300A | Arylamino fused pyrimidines | Chemistry; Metallurgy | 22 | Expired |
| US6124300A | Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives | Human Necessities | 19 | Expired |
| US7482470B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Chemistry; Metallurgy | 18 | Active |
| US6258809A | 6-aryloxy and arylthiopurines | Human Necessities | 17 | Expired |
| US4704382A | Phenylpiperazine phosphonates | Physics | 14 | Expired |
| US7666889B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Chemistry; Metallurgy | 14 | Active |
| US8088809B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Chemistry; Metallurgy | 12 | Active |
| US6358950B1 | Azolo triazines and pyrimidines | Chemistry; Metallurgy | 11 | Expired |
| US6136809A | Azolo triazines and pyrimidines | Chemistry; Metallurgy | 9 | Expired |
| US7687481B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating obesity | Chemistry; Metallurgy | 9 | Active |
| US10793519B2 | Ultra short acting anti-arrhythmic agents | Chemistry; Metallurgy | 8 | Active |
| US11286235B2 | Ultra short acting anti-arrhythmic agents | Chemistry; Metallurgy | 7 | Active |
| US8334282B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Human Necessities | 7 | Active |
| US4230626A | 25-Halocholest-5-ene-3.beta.,22-diols and esters thereof | Chemistry; Metallurgy | 7 | Expired |
| US9517228B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Chemistry; Metallurgy | 7 | Active |
| US9987253B2 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Chemistry; Metallurgy | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.